ZNF545 Activators encompass a range of chemical compounds that indirectly boost the functional activity of ZNF545 by targeting various cellular mechanisms. Forskolin, through its action on adenylate cyclase, raises intracellular cAMP levels, subsequently activating PKA, which may enhance ZNF545 activity by phosphorylating transcription factors that modulate its function. Similarly, retinoic acid and its interaction with nuclear receptors could lead to an increased DNA-binding affinity of ZNF545, potentially augmenting its transcriptional regulation. Histone deacetylase inhibitors such as Trichostatin and Sodium butyrate alter the chromatin landscape, making target DNA sequences more accessible to ZNF545, thus potentially amplifying its transcriptional impact. The inhibition of DNA methyltransferase by 5-Azacytidine also contributes to a more transcriptionally active chromatin state, which may facilitate ZNF545's regulatory role. Furthermore, the presence of bioavailable zinc from Zinc sulfate is crucial for the structural integrity and DNA binding capability of ZNF545, suggesting an enhancement of its activity upon supplementation. The activation of PKC by Phorbol 12-myristate 13-acetate (PMA) could indirectly stimulate ZNF545 by altering the phosphorylation status of proteins involved in transcriptional regulation, while Epigallocatechin gallate (EGCG) inhibits kinases that may otherwise negatively regulate ZNF545, suggesting a potential upregulation of its activity.
Additionally, Dibutyryl-cAMP (db-cAMP) mimics the action of cAMP and activates PKA, leading to the phosphorylation of proteins that can interact and potentially enhance the activity of ZNF545. Curcumin's inhibition of NF-κB could lead to a rebalancing of gene expression levels, potentially enhancing the activity of ZNF545 as a compensatory mechanism. Lastly, Resveratrol activates sirtuins, which may modify the activity of both histones and transcription factors, leading to a possible increase in ZNF545 function through changes in chromatin dynamics and transcription factor interactions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, resulting in increased cAMP levels within cells. Elevated cAMP activates PKA, which can phosphorylate transcription factors, potentially enhancing the transcriptional regulatory activity of ZNF545. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid binds to retinoic acid receptors which can heterodimerize with other nuclear receptors. These complexes can interact with the DNA binding domains of zinc finger proteins like ZNF545, potentially enhancing their DNA-binding affinity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that leads to a more relaxed chromatin state. This can enhance the access of ZNF545 to its target DNA sequences, thereby increasing its functional activity as a transcription factor. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine inhibits DNA methyltransferase, leading to hypomethylation of DNA. Demethylated promoter regions may be more accessible to transcription factors like ZNF545, potentially enhancing its regulatory functions. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is another histone deacetylase inhibitor, which can increase the accessibility of chromatin for transcription factors. This can indirectly enhance the activity of ZNF545 by facilitating its binding to DNA. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc is a cofactor for many zinc finger proteins, including ZNF545. Zinc sulfate can increase the concentration of bioavailable zinc, potentially enhancing the structural stability and DNA binding capability of ZNF545. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate a wide range of targets, including proteins that modulate transcription factors. This can lead to enhanced activity of ZNF545 through altered transcriptional regulation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several protein kinases, which might relieve negative regulatory constraints on transcription factors. By inhibiting these kinases, EGCG could indirectly enhance the transcriptional activity of ZNF545. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable cAMP analog that activates PKA. By mimicking cAMP, it can promote the phosphorylation of proteins that interact with ZNF545, potentially enhancing ZNF545's transcriptional activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can inhibit NF-κB, which may lead to altered expression of genes that are also targets of ZNF545. This could result in a compensatory enhancement of ZNF545 activity to maintain gene regulation homeostasis. | ||||||